Menu
Menu
Newsletter
Menu
Newsletter
Webjet Group
Travel Stocks
Webjet Group (ASX:WJL) Falls 25% on Failed Takeover and Downgraded Guidance- Value Trap or Hidden Opportunity?
Webjet Group Plunges After Takeover Collapse Webjet Group (ASX: WJL) plunged 25 per cent to A$0.58 on Friday, marking its largest single-day drop since listing on the ASX. Both potential acquirers, Helloworld Travel (ASX: HLO) at 90 cents per share and private equity firm BGH Capital at 91 cents, walked away without making binding offers…
February 14, 20260Comments
Syrah Resources
Mining Stocks
Syrah Resources (ASX:SYR) Climbs 6% as US Graphite Tariff Case Advances- A Speculative Buy for Patient Investors?
Syrah Resources Surges on Tariff Boost Syrah Resources (ASX: SYR) rose 6.4% this week to A$0.25 after the US trade case against Chinese graphite moved closer to a final decision. The US Department of Commerce has confirmed combined anti-dumping and countervailing tariffs of at least 160 per cent on graphite anode material imported from China.…
February 13, 20260Comments
Centuria Industrial
Property
Centuria Industrial REIT (ASX:CIP) Upgrades Earnings- Is It a Buy at 18% Below Asset Value?
Centuria Industrial Trades at a Big Discount, Despite an Earnings Upgrade Centuria Industrial REIT (ASX: CIP) has delivered something investors don’t often see: a property trust that is growing its earnings, increasing its forecast, and still trading at a discount. The company has raised its expected earnings (FFO) for FY26 to 18.2-18.5 cents per unit,…
February 12, 20260Comments
Rhythm Biosciences
Healthcare Stocks
A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step
Rhythm Biosciences Starts ColoSTAT Pilot, Revenue Still Unclear Rhythm Biosciences (ASX: RHY) just hit a milestone the market has been waiting for, enrolling its first doctor in the ColoSTAT Access Program, a small pilot program that will test its blood-based bowel cancer screening product in real clinical settings for the first time. The share price…
February 12, 20260Comments
Evolution Mining
Mining Stocks
Evolution Mining (ASX:EVN) Surges 9% on Record $767M Profit- So Why Do Most Analysts Still Say Sell?
Evolution Mining Hits Record Profit, But Is It Priced Too High? Evolution Mining (ASX: EVN) shares jumped almost 9% after the company reported the best half-year result in its 14-year history. Net profit more than doubled, rising 110% to AUD 766.6 million, while revenue increased 37% to AUD 2.79 billion. The company also announced a record…
February 12, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here